Received Feb 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
Eczema; This is a spontaneous report received from an Other HCP. A 67-year-old male patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Lisinopril, reaction(s): "Allergy". The following information was reported: ECZEMA (non-serious), outcome "unknown". The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.